Labrador drops BioFire suit after COVID-19 revelation

Labrador Diagnostics has dropped its controversial patent complaint against COVID-19 test developer BioMerieux.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Medtech

COVID-19: governments look to shield companies from IP enforcement

23 April 2020 The UK government’s indemnifying of ventilator manufacturers is a smart solution to potential licensing obstacles, says Andrew Pitts of Mewburn Ellis.

Americas

Fortress offers licences after COVID-19 testing patent backlash

19 March 2020 Labrador Diagnostics, a subsidiary of Fortress Investment Group, has offered royalty-free licences to third parties for its patent-protected diagnostics technology, just days after suing US-based health startup BioFire, which is attempting to develop COVID-19 testing kits.

More on this story

Medtech

COVID-19: governments look to shield companies from IP enforcement

23 April 2020 The UK government’s indemnifying of ventilator manufacturers is a smart solution to potential licensing obstacles, says Andrew Pitts of Mewburn Ellis.

Americas

Fortress offers licences after COVID-19 testing patent backlash

More on this story

Medtech

COVID-19: governments look to shield companies from IP enforcement

23 April 2020 The UK government’s indemnifying of ventilator manufacturers is a smart solution to potential licensing obstacles, says Andrew Pitts of Mewburn Ellis.

Americas

Fortress offers licences after COVID-19 testing patent backlash